Still in pain despite medication for trigeminal neuralgia? When should you consider a nerve block?
Still in pain despite medication for trigeminal neuralgia? When should you consider a nerve block?
Article Summary
When medication provides limited relief for trigeminal neuralgia, the next step is not to immediately undergo the same injection or surgery, but to first schedule a consultation for a re-diagnosis.
Both classic trigeminal neuralgia and painful trigeminal neuropathy cause facial nerve pain, but their pain patterns, underlying causes, and appropriate treatments are not entirely the same.
If painful trigeminal neuropathy has been confirmed, symptoms persist, medications offer limited efficacy, or side effects become intolerable, a physician may further evaluate the option of a peripheral trigeminal nerve block. This treatment is not suitable for every type of facial pain, nor should you decide to undergo this procedure based solely on symptom checklists found online.
Why Is It Crucial to Distinguish Between the Types of Trigeminal Pain First?
Classic trigeminal neuralgia often manifests as brief, severe, electric shock-like unilateral pain; painful trigeminal neuropathy, on the other hand, frequently presents with more persistent burning, tingling, numbness, or abnormal sensations (dysesthesia). The two can have overlapping symptoms, but physicians apply different clinical reasoning when selecting medications, nerve blocks, or surgery. Facial pain can also originate from teeth, the temporomandibular joint, herpes zoster, tumors, inflammation, or other neurological disorders. If the pain source is not confirmed beforehand and the trigeminal nerve is treated directly, the true underlying cause of the pain may remain unaddressed.
What Is a Trigeminal Nerve Block?
A peripheral trigeminal nerve block involves injecting a local anesthetic near the branch of the trigeminal nerve corresponding to the pain distribution. Depending on individual circumstances, some treatments combine this with a steroid injection. The goal is to reduce pain signals and local inflammatory responses; this approach differs from neurodestructive procedures. Determining which branch to block, whether to use image guidance, and which medications to select depends on the pain location, neurological examination, and comorbidities.
Who Might Be Suitable for Diagnosis and Evaluation?
Patients confirmed by a physician to have painful trigeminal neuropathy, rather than simple toothache or other forms of facial pain.
Patients whose pain has persisted for a period and matches the anatomical distribution of the trigeminal nerve.
Patients who have tried medications according to their diagnosis, but still experience limited relief or lifestyle-disrupting side effects.
Patients in whom examination reveals localized tenderness, pain triggered by touch, or other sensory abnormalities.
Patients who, after evaluation by a physician, have no contraindications to injections or the specific medications used.
A nerve block is usually not the first step, nor is it the standard solution for all cases of classic trigeminal neuralgia. If the pain stems from structural compression, tumors, infections, or other causes, management will focus on treating the underlying condition.
What Did Dr. Yu-Chia Chen's Research Discover?
A 2026 retrospective study with Dr. Yu-Chia Chen as the lead author reviewed medical records of 90 patients with painful trigeminal neuropathy who received peripheral trigeminal nerve blocks at Massachusetts General Hospital between 2023 and 2025. These patients had symptoms persisting for at least three months and had previously tried at least two medications.
In the study, 73 patients (81.1%) achieved at least a 50% reduction in their pain scores; 45 patients (50.0%) maintained this relief for at least six weeks, 33 patients (36.7%) for at least eight weeks, and 21 patients (23.3%) for at least twelve weeks.
Adverse effects documented in the medical records included pain and bruising at the injection site. As a single-center retrospective chart review, the study lacked a placebo control group and may have been influenced by follow-up rates and patient selection.
This study provides evidence that this approach "merits further clinical evaluation"; it does not imply that every patient will achieve the same treatment outcome. The study also excluded other diagnoses such as classic trigeminal neuralgia, so the 81.1% figure cannot be applied directly to everyone searching for "trigeminal neuralgia."
What Risks Need to Be Reviewed Before Treatment?
Potential reactions vary depending on the injection site and the medications used; they include localized pain, bruising, bleeding, infection, transient numbness, and individual adverse reactions to local anesthetics or steroids. Patients who are taking anticoagulants, have drug allergies, have active or uncontrolled infections, or have blood sugar and blood pressure issues should proactively inform their physician before treatment.
At the Special Clinic for Head & Neck Pain and Vertigo at Hsi Clinic, Dr. Yu-Chia Chen provides consultations, comprehensive facial pain evaluations, and medication adjustments. When deemed appropriate after evaluation, peripheral nerve blocks and trigeminal nerve blocks can be arranged. Please allocate approximately one hour for initial visits; if you have previous dental or other medical examination reports, feel free to bring them with you. If you wish to make an appointment, you can inquire and register via Hsi Clinic's official LINE account.
Frequently Asked Questions
Is a trigeminal nerve block a surgical procedure? A peripheral nerve block is generally an injection-based therapy rather than an open craniotomy. It differs from radiofrequency ablation and is not a balloon compression or other neurodestructive procedure. The specific procedure name and approach should always be explained by the treating physician.
Will a single nerve block cure the condition? Not necessarily. The duration of relief varied significantly in the study: some patients experienced insufficient relief, while others maintained benefits for several weeks or longer. Whether repeated treatments are necessary depends on the diagnosis, the initial response after treatment, concurrent medications, and the overall management plan.
The study states 81.1%; does that mean I also have an 80% chance of it being effective? It cannot be converted directly like that. The 81.1% figure was observed in a cohort with clearly defined criteria: diagnosed with painful trigeminal neuropathy, symptoms lasting at least three months, having tried at least two prior medications, and excluding other diagnoses like classic trigeminal neuralgia. This was a single-center retrospective chart review without a placebo control. It demonstrates that this treatment is worth evaluating, but each individual's diagnosis, clinical course, and medication history differ; actual effectiveness can only be determined after a physician's evaluation.
Author: Dr. Yu-Chia Chen
Last Updated: 2026/10/26
Disclaimer: This article provides health education information and cannot replace professional medical diagnosis and treatment advice. The suitability of any treatment must be determined by a physician after clinical evaluation.
